[New data on cytoprotection in radiotherapy].
Sauer
R
R
Strnad
V
V
D004999:Amifostine / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology*; D000970:Antineoplastic Agents / Q000627:therapeutic use; D016190:Carboplatin / Q000627:therapeutic use; D003131:Combined Modality Therapy; D019610:Cytoprotection; D004311:Double-Blind Method; D005500:Follow-Up Studies; D006258:Head and Neck Neoplasms / Q000188:drug therapy / Q000532:radiotherapy* / Q000601:surgery; D006801:Humans; D010865:Pilot Projects; D010919:Placebos; D011182:Postoperative Care; D011300:Preoperative Care; D011837:Radiation-Protective Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology*; D011878:Radiotherapy / Q000009:adverse effects*; D016032:Randomized Controlled Trials as Topic; D013280:Stomatitis / Q000209:etiology / Q000517:prevention & control; D013997:Time Factors; D014987:Xerostomia / Q000209:etiology / Q000517:prevention & control
D000970:Antineoplastic Agents; D010919:Placebos; D011837:Radiation-Protective Agents; D016190:Carboplatin; D004999:Amifostine
Neue Daten zur Zytoprotektion in der Strahlentherapie.